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ABSTRACT
Objective: The purpose of this work is to evaluate the antimicrobial, antibacterial, and hypoglycemic effects of methanolic and ethanolic extracts of 
Embelia ribes leaves using in vitro studies.
Methods: Antibacterial activities of the methanolic and ethanolic extract of E. ribes leaves against Escherichia coli, Staphylococcus aureus, Enterococci, 
and Klebsiella pneumoniae at different concentrations ranging from 10, 25, 50, and 75 μg/mL and their antibacterial activities were compared to those 
of the reference controls such as ciprofloxacin and clindamycin. Furthermore, the effect of leaf extracts on α-amylase and α-glucosidase enzymes was 
assayed.
Results: The methanolic and ethanolic extract of E. ribes leaves effectively inhibited the activity of α-amylase and α-glucosidase in a dose-dependent 
manner. The effect of the methanolic extract was more prominent than that of ethanolic extract. At the same time, both the extracts showed markable 
inhibition of bacterial growth at a concentration of 75 μg/mL compared to the other three doses (10, 25, and 50 μg/ml) and also commercially 
available antibiotic drugs ciprofloxacin and clindamycin that were used as positive control drugs. The antibacterial activity of methanolic extract is 
significantly higher than that of ethanolic extract.
Conclusion: The preliminary results of this study have put forward E. ribes into promising herb with respect to its therapeutic potential although 
further studies are needed to evaluate its mechanism of action.
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INTRODUCTION
In recent years, it has been observed that there has been a shift in 
universal trend from synthetic to herbal medicines which involve 
the use of plants for medicinal and therapeutic purpose and also to 
improve overall human health [1]. It has been well documented that 
both herbal plants and their derivatives play critical roles in modern 
drug development, in addition, with the rise of medicinal plants as the 
natural resources in the development of new drugs [2]. Hence, there is 
a need in advance research for the development and characterization of 
new natural drugs with the aid of better screening methods from plants 
and other natural sources.
Antibiotics are the main basis for the therapy of microbial (bacterial 
and fungal) infections [3]. However, most of the existing antimicrobial 
compounds prescribed today are in danger for losing their efficacy 
because of the increased microbial resistances [4]. In recent times, 
its impact is considerable with treatment failures associated with 
multidrug-resistant bacteria, and it has become a global concern to public 
health [5,6]. Hence, new leads in screening of drugs are being made 
from natural sources. There are several studies that have reported the 
antimicrobial and antibacterial activity of different herbal extracts [7,8]. 
Hence, plants continue to provide a good source for new drugs [9].
Diabetes is a multifactorial disease with diabetic patients more 
prone to fatal complications such as chronic diabetes microvascular 
complications, episodes of hypoglycemia, and poor glycemic control. 
Hence, the use of antidiabetic medications and glucose-lowering drugs 
may have an impact on metabolism and the risk associated with their 
use is afflicting many people, from various walks of life in different 
countries. India presently has the largest number of diabetic patients 
in the world and has been infamously dubbed as the diabetic capital of 
the world [10].
Herbal formulations are preferred nowadays due to lesser side effects 
and low cost, although many drugs are available, they have many side 
effects [11]. In recent times, there is growing interest in herbal remedies 
due to the side effects associated with the oral hypoglycemic agents for 
the treatment of diabetes [12].
The chief enzymes responsible for metabolizing polysaccharides 
into monosaccharides are pancreatic a-amylase and a-glucosidase 
in intestine. The action of these enzymes causes postprandial blood 
glucose level elevation due to absorption of formed glucose from 
polysaccharides in the small intestine. Drugs which have an inhibitory 
action on both of these enzymes possess an ability to control 
postprandial blood glucose level specifically in type 2 diabetic patients 
[13]. Acarbose and miglitol are the most commonly prescribed drugs 
which competitively inhibit above enzymes. However, both of these 
drugs do have common side effects such as flatulence and abdominal 
bloating [14,15]. Hence, new drugs or formulations which are devoid 
of the above side effects will improve the compliance in type 2 diabetic 
patients. Plants have been an exemplary source of drugs, and it is 
reported that about 800 plants may possess antidiabetic potential 
[16]. Medicinal plants exhibit their hypoglycemic activity through 
their ability to restore the function of pancreatic tissues by causing a 
rise in insulin output, inhibiting the intestinal absorption of glucose, or 
facilitating metabolites in insulin-dependent processes [17,18].
Embelia ribes is a large woody shrub with slender branches and gland-
dotted leaves. It is distributed in moist deciduous forests of the Western 
Ghats of South India, Jammu and Kashmir, Himachal Pradesh, Uttar 
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Pradesh, Assam and Maharashtra, Sri Lanka, Malaya, Singapore, and 
South China.
The plant has been reported to contain minute quantities of a 
volatile oil, quinone derivative embelin (3-Undecyl 2, 5-dihydroxy, 
1, 4-benzoquinone), quercitol, and fatty ingredients; an alkaloid, 
christembine, a resinoid, and tannins [19,20]. Other components that 
have been reported include christembine, quercitol, vilangin, and 
resinoid. The dried fruits are being used for the preparation of medicine. 
It is widely used as antihelminthic, anticarminative, antibacterial, anti-
inflammatory, antidiuretic, and anti-astringent [21]. Embelin has been 
also reported as a potent inhibitor of NF-κB activation, which makes it 
a potentially effective suppressor of tumor cell survival, proliferation, 
invasion, angiogenesis, and inflammation and has great potential as a 
therapeutic agent for osteoporosis and cancer-linked bone loss [22,23].
The fruits of E. ribes are known to have various pharmacological 
and therapeutic effects such as antioxidant, hepatoprotective, 
antihyperglycemic, cardioprotective, neuroprotective, and antitumor 
effects [24]. With this background, not much work has been carried 
out on the antimicrobial and antihyperglycemic effect of E. ribes 
leaves. Hence, the present study was designed to evaluate the in vitro 
antimicrobial and hypoglycemic effects of the methanolic and ethanolic 
leaf extracts of E. ribes.
METHODS
Plant material
Leaves of E. ribes were procured from the Institute of Trans-Disciplinary 
Health Sciences and Technology, Bangalore, India. The samples were 
authenticated by Dr. N.M.Ganesh Babu, Head, Centre for Herbal Gardens, 
from the same institute.
Extraction procedure
Methanol and aqueous extracts were selected because they have been 
reported to be among the best solvents for the extraction of antioxidant 
compounds. 50 g of the dry leaves of E. ribes was weighed accurately 
and soaked in 50 ml of the two solvents (methanol and ethanol) 
separately and kept in a dark place for 3 d in a shaker. Carbon dioxide 
was released frequently. After 3 days, samples were filtered and the 
filtrates were kept in a water bath at about 40°C to concentrate them. 
The concentrated filtrates obtained were used for further studies at 
different concentrations.
Alpha-amylase assay
Alpha-amylase activity was carried out as reported by Roux et al. [25]. 
The assay mixture consisting of 120 µl phosphate buffer (40 mM) 
pH 6.9, along with test sample of various concentrations (dissolved 
in 1% methanol) and positive control (acarbose) was preincubated 
with 60 µl of enzyme at 37°C for 10 min. The substrate reagent 250 µl 
(CNPG3) was added and incubated at 37°C for 8 min. Control tubes 
were run devoid of test samples. The absorbance was measured at 
405 nm using Tecan Microplate Reader.
Alpha-glucosidase assay
Alpha-glucosidase activity was carried out as reported by Matsuo 
et al. [26]. The assay mixture consisting of 250 µl phosphate buffer 
(40 mM) pH 6.9, along with test sample of various concentrations 
(dissolved in 1% methanol) and positive control (acarbose) was 
preincubated with 50 µl of enzyme at 37°C for 30 min. 500 µl of sucrose 
solution was added and incubated at 37°C for 20 min, heated on a 
boiling water bath for 2 min to arrest the reaction and then cooled. The 
glucose concentration was measured by glucose oxidase method.
Glucose oxidase method
100 µl of the sample was mixed with 500 µl of glucose reagent (Glucose 
reagent kit) and incubated at room temperature for 10 min. The 
absorbance was measured at 510 nm using semi autoanalyzer (Erba 
Chem).
Antibacterial studies
The bacterial strains Staphylococcus aureus (ATCC 25923), Enterococcus 
species, Escherichia coli (ATCC 8739), and Klebsiella pneumonia (ATCC 
BAA 1705) were obtained from the microbiology clinical laboratory 
which was used for the evaluation of antimicrobial activity. Fresh 
bacterial cultures were prepared by subculturing stock bacterial 
cultures into freshly prepared nutrient agar and incubating at 37°C for 
24 h. These 24 h old bacterial cultures were transferred into freshly 
prepared nutrient broth and standardized to 0.5 McFarland turbidity 
standards using the spectrophotometer to obtain the desired cell 
density of 1.5×108 (cells/ml). The 0.5 McFarland turbidity standard 
was prepared by adding 0.05 ml of 1.175 % of barium chloride dihydrate 
(BaCl2•2H2O), with 9.95 ml of 1% sulfuric acid.
Screening for the antimicrobial potential of the plant
The bacteria cultures were grown in nutrient agar medium at 37°C. 
After 6 h of growth, each microorganism, at a concentration of 
106 cells/ml, was inoculated on the surface of Mueller-Hinton agar 
plates. Subsequently, filter paper discs (6 mm in diameter) saturated 
either with E. ribes extract (25 μl) were placed on surface of each 
inoculated plate. To evaluate the efficiency of the methodology, each 
extract was inserted simultaneously in a whole made (50 μl) in new 
plates. The plates were incubated at 37°C for 24 h. After this period, 
it was possible to observe inhibition zone. Overall, cultured bacteria 
with halos equal to or >7 mm were considered susceptible to either the 
tested extract or phytochemical. Dimethyl sulfoxide (2%) was used to 
dissolve the extracts in the culture media when necessary. The controls 
were the solvents used for each extract, and the phytochemicals showed 
no inhibitions in preliminary studies.
RESULTS AND DISCUSSION
Hypoglycemic activity of the leaf extract of E. ribes
Alpha-amylase and alpha-glucosidase are responsible for the hydrolysis 
of poly- and oligosaccharides into monomers or cleavage of bonds 
between sugars and non-carbohydrate aglycone. These enzymes 
are involved in a number of important biological processes such as 
digestion of carbohydrate into glucose [27]. There is now a great deal 
of interest in amylase and glucosidase inhibitors because these are 
important biochemical tools for studying the mechanism of enzymes. 
The search for amylase and glucosidase inhibitors has yielded a number 
of chemically distinct inhibitors from plants [28].
Alpha-glucosidase and alpha-amylase concentration determined 
in ethanolic and methanolic extracts of E. ribes leaves at various 
concentrations and acarbose was used as a standard (Figs. 1 and 2). 
α-glucosidase activity was significantly inhibited by methanolic extracts 
whereas compared with ethanolic extracts in a dose-dependent 
manner (Fig. 1). Whereas α-amylase activity was significantly inhibited 
by methanolic extracts whereas compared with ethanolic extracts in a 
dose-dependent manner (Fig. 2). α-amylase inhibitors obtained from 
natural herbal-based food sources suggest an attractive therapeutic 
move toward the treatment of postprandial hyperglycemia, and this is 
done by decreasing glucose release from starch and may likely find its 
use in the treatment of diabetes mellitus and obesity [29]. The outcome 
of the present investigation is in agreement with other reports [30-32]. 
The postprandial glucose suppression through α-glucosidase inhibitory 
action by methanol extracts of E. ribes showed potent inhibitory activity, 
while less inhibitions were observed in ethanolic extract of E. ribes. The 
retardation of membrane-bound α-glucosidase inhibitory reaction or 
inhibition of passive glucose transport would successfully flatten the 
postprandial blood glucose excursions or reduce hyperglycemia. On the 
basis of these results, methanolic extracts of E. ribes showed strongest 
α-glucosidase inhibitory activity than ethanolic extract of E. ribes leaves.
Inhibition of α-amylase and α-glucosidase might lead to delay in 
carbohydrate digestion and glucose absorption resulting in the 
diminishing of postprandial hyperglycemic excursions. These inhibitors 
most often do not whole alter the amount of carbohydrate absorbed. 
Hence, they influence only the carbohydrate digestion without resulting 
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in any nutritional caloric loss. Persistent hyperglycemia after intake 
of food could provoke the non-enzymatic glycosylation of a variety of 
proteins, ensuing in the progress of chronic complications. Thus, control 
of glucose levels after intake of meal is crucial in the early management of 
diabetes mellitus and in ameliorating the chronic vascular complications.
Most of the antidiabetic drugs exhibit their effect by raising the insulin 
secretion and/or by recuperating insulin action [29]. Sulfonylurea-
induced insulin secretion by clamping open ATP-sensitive K++ channels, 
thus preventing membrane depolarization and subsequent Ca+2+ influx, 
two of the key initial steps in insulin secretion [33]. In the present study, 
E. ribes had significant effects on insulin secretion and stimulated more 
than 2-fold insulin release. The extract is, therefore, likely to act at an 
early stage of the insulin secretion pathway before Ca+2+ influx. These 
characteristics are indicative of sulfonylureas, and this study shows 
that the antihyperglycemic actions of E. ribes are associated with the 
stimulation of insulin secretion.
Antibacterial and antimicrobial activities of the leaf extract of 
E. ribes
The antibacterial activities of the extracts against both Gram-positive 
organisms E. coli, S. aureus, Enterococci, and Klebsiella pneumoniae at 
different concentrations ranging from 10, 25, 50, and 75 µg/ml and 
their antibacterial activities were compared to those of the reference 
controls (ciprofloxacin and clindamycin). The antibacterial activity 
of the extracts was found to increase with increasing concentration 
against all bacterial strains tested, as evidenced by the higher zones 
of inhibition at higher concentrations (Figs. 3 and 4). Moreover, the 
extracts showed a remarkable inhibition of bacterial growth at a 
concentration of 75 µg/ml compared to the other doses (10, 25, and 
50 μg/ml), and the activities are comparable to (ciprofloxacin and 
clindamycin) a commercially available antibiotic drug that was used as 
the reference control drug.
The extract was significantly active, exhibiting antimicrobial activity 
against tested organisms, namely E. coli, S. aureus, Enterococci, and 
K. pneumoniae. The antibacterial activity of the extracts was found to 
increase with increasing concentration against all bacterial strains 
tested, as evidenced by the higher zones of inhibition at higher 
concentrations. Both the extracts showed are markable inhibition 
of bacterial growth at a concentration of 75 μg/ml compared to the 
other three doses (10, 25, and 50 μg/ml) and commercially available 
antibiotic drug (ciprofloxacin and clindamycin) that was used as a 
reference positive control drug. The antibacterial activity of methanolic 
Fig. 1: Effect of Embelia ribes on the activity of alpha-amylase. Alpha-amylase concentration determined in ethanolic and methanolic 
extracts of E. ribes leaves at various concentrations and positive control (acarbose) was used as a standard. Each bar represents mean ± 
standard error of the mean of five sets. Each first bar reveals α-amylase activity was significantly inhibited by methanolic extract when 
compared with ethanolic extracts in a dose-dependent manner
Fig. 2: Effect of Embelia ribes on the activity of alpha-glucosidase. Alpha-glucosidase concentration determined in ethanolic and 
methanolic extracts of E. ribes leaves at various concentrations and positive control (acarbose) was used as a standard. Each bar 
represents mean ± standard error of the mean of five sets. Each first bar reveals α-glucosidase activity was significantly inhibited by 
methanolic extracts whereas compared with ethanolic extracts in a dose-dependent manner
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extract is significantly higher than that of ethanolic extract. These 
results support the view of developing new antibacterial drugs from 
the leaf extract of E. ribes [34].
CONCLUSION
In the present study, in vitro hypoglycemic activity of methanolic 
and ethanolic extracts of E. ribes leaves on alpha-amylase and alpha-
glucosidase activity was studied, and it was observed that both the 
extracts have an antidiabetic activity but when compared to ethanolic 
extract, the methanolic extracts of E. ribes leaves had a higher inhibitory 
activity on alpha-amylase and alpha-glucosidase enzymes. Similar 
results were obtained when the antimicrobial and antibacterial activity 
of the leaf extracts were studied. From the results of the present study, 
it can be inferred that the methanolic extract of the leaves of E. ribes 
holds more therapeutic potential when compare with the ethanolic 
extract and further studies are needed to find out the active component 
responsible for the antibacterial and hypoglycemic efficacy of the E. 
ribes leaves.
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